TPB · Turning Point Brands, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $0.76 | Q1 2026 | — |
| Adjusted EBITDA non-GAAP | $25.9M | Q1 2026 | — |
| Asset backed revolving credit facility capacity | $68.1M | As of December 31, 2025 | — |
| Modern Oral Net Sales | $41.3M | Q4 2025 | — |
| Net debt | $77.2M | As of December 31, 2025 | — |
| Total liquidity | $290.1M | As of December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Tobacco — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TPB
this stock
Turning Point Brands, Inc.
|
$1.56B | -25.5% | +28.4% | 26.0 | 13.1% |
|
PM
Philip Morris International Inc.
|
$311.99B | +25.9% | +10.7% | 28.8 | 1.1% |
|
BTI
British American Tobacco p.l.c.
|
$134.42B | +11.6% | — | — | 0.3% |
|
MO
Altria Group, Inc.
|
$125.09B | +31.9% | -3.1% | 15.6 | 3.2% |
|
RLX
RLX Technology Inc.
|
$2.49B | -14.6% | +50.3% | — | 0.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TPB | +1.4% | -4.6% | -36.2% | -4.9% | -25.5% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +2.4% | -4.5% | -43.7% | -4.1% | -34.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.